FDA-Approved dialysis device under Long-Term watch
NCT ID NCT07146854
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tracks 150 adults with end-stage kidney disease who use the EndoForce System to connect a dialysis graft to a vein. The device is already FDA-approved, so this is not an experiment—it's a check on long-term safety and how well it works over time. Researchers will monitor for complications like infections or blockages and measure how long the graft stays usable for dialysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EndoForce System (device for connecting hemodialysis graft to vein)
What this could lead to
If successful, this study could confirm that the EndoForce System is a safe and reliable option for hemodialysis access in kidney failure patients.
What could go wrong
This is an observational study, not a test of a new treatment. The device is already approved, so no major breakthroughs are expected. Risks include device-related complications like infection or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MUSC Health Orangeburg
NOT_YET_RECRUITINGOrangeburg, South Carolina, 29118, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Spartanburg Regional Medical Center
RECRUITINGSpartanburg, South Carolina, 29303, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••